|Application ||WB, IHC-P, E|
|Dilution||ELISA (1:64000), IHC-P (5 µg/ml), WB (1-3 µg/ml)|
|Other Names||Melanoma-derived growth regulatory protein, Melanoma inhibitory activity protein, MIA|
|Target/Specificity||Human MIA. The immunizing peptide represents the N terminus of the mature protein. Reported variants represent identical protein: NP_006524.1, NP_001189482.1,|
|Reconstitution & Storage||Store at -20°C. Minimize freezing and thawing.|
|Precautions||MIA Antibody (Internal) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Elicits growth inhibition on melanoma cells in vitro as well as some other neuroectodermal tumors, including gliomas.|
|Tissue Location||All malignant melanoma cell lines tested and infrequently in glioma cell lines|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Elicits growth inhibition on melanoma cells in vitro as well as some other neuroectodermal tumors, including gliomas.
Blesch A.,et al.Cancer Res. 54:5695-5701(1994).
Bosserhoff A.-K.,et al.J. Biol. Chem. 271:490-495(1996).
Hau P.,et al.J. Invest. Dermatol. 119:562-569(2002).
Kalnine N.,et al.Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
Ebert L.,et al.Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.